{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:58:09Z","timestamp":1788209889840,"version":"build-2803163510"},"reference-count":38,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"unspecified","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"crossref","award":["20K08815"],"award-info":[{"award-number":["20K08815"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2024,5,31]]},"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The tuning effects of JAK\/TYK2 inhibitors on the imbalance between T follicular helper (Tfh) and T regulatory (Treg) cells, related to systemic lupus erythematosus (SLE) pathogenesis, were investigated using human peripheral blood samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Peripheral blood mononuclear cells from untreated patients with SLE and healthy controls were analysed. Tfh1 cells were identified in nephritis tissue, and the effect of Tfh1 cells on B-cell differentiation was examined by coculturing na\u00efve B cells with Tfh1 cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Tfh1 cell numbers were increased in the peripheral blood of patients, and activated Treg cell counts were decreased relative to Tfh1 cell counts. This imbalance in the Tfh to Treg ratio was remarkably pronounced in cases of lupus nephritis, especially in types III and IV active nephritis. Immunohistochemistry revealed Tfh1 cell infiltration in lupus nephritis tissues. Co-culture of Tfh1 cells (isolated from healthy individuals) with na\u00efve B cells elicited greater induction of T-bet\n                      <jats:sup>+<\/jats:sup>\n                      B cells than controls. In JAK\/TYK2-dependent STAT phosphorylation assays using memory CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells, IL-12-induced STAT1\/4 phosphorylation and Tfh1 cell differentiation were inhibited by both JAK and TYK2 inhibitors. However, phosphorylation of STAT5 by IL-2 and induction of Treg cell differentiation by IL-2+TGF\u03b2 were inhibited by JAK inhibitors but not by TYK2 inhibitors, suggesting that TYK2 does not mediate the IL-2 signalling pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Tfh1 cells can induce T-bet\n                      <jats:sup>+<\/jats:sup>\n                      B cell production and may contribute to SLE pathogenesis-associated processes. TYK2 inhibitor may fine-tune the immune imbalance by suppressing Tfh1 differentiation and maintaining Treg cell differentiation, thereby preserving IL-2 signalling, unlike other JAK inhibitors.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003991","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T14:01:18Z","timestamp":1718287278000},"page":"e003991","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus"],"prefix":"10.1136","volume":"10","author":[{"given":"Yurie","family":"Satoh-Kanda","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Nakayamada","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9693-9263","authenticated-orcid":false,"given":"Satoshi","family":"Kubo","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"},{"name":"Department of Molecular Targeted Therapies (DMTT), University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Yamagata","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7871-2425","authenticated-orcid":false,"given":"Aya","family":"Nawata","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"},{"name":"Department of Pathology and Oncology, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunpei","family":"Kosaka","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"},{"name":"Department of Pathology and Oncology, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichiro","family":"Kanda","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Yu","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"},{"name":"Department of Pediatrics, Shenyang Women\u2019s and Children\u2019s Hospital, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Fujita","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4003-8842","authenticated-orcid":false,"given":"Koshiro","family":"Sonomoto","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0807-7139","authenticated-orcid":false,"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"2025090312054826000_10.2.e003991.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218272"},{"key":"2025090312054826000_10.2.e003991.2","doi-asserted-by":"crossref","first-page":"621105","DOI":"10.3389\/fimmu.2021.621105","article-title":"Multi-source pathways of T follicular helper cell differentiation","volume":"12","author":"Ma","year":"2021","journal-title":"Front Immunol"},{"key":"2025090312054826000_10.2.e003991.3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/25785826.2020.1776079","article-title":"T follicular helper cell Subsets: a potential key player in Autoimmunity","volume":"44","author":"Kurata","year":"2021","journal-title":"Immunol Med"},{"key":"2025090312054826000_10.2.e003991.4","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3054"},{"key":"2025090312054826000_10.2.e003991.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2021.04.006"},{"key":"2025090312054826000_10.2.e003991.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2019.06.005"},{"key":"2025090312054826000_10.2.e003991.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212652"},{"key":"2025090312054826000_10.2.e003991.8","doi-asserted-by":"publisher","DOI":"10.1002\/EJI.201948134"},{"key":"2025090312054826000_10.2.e003991.9","doi-asserted-by":"publisher","DOI":"10.1177\/1535370218824547"},{"key":"2025090312054826000_10.2.e003991.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075319","article-title":"Circulating TFH subset distribution is strongly affected in lupus patients with an active disease","volume":"8","author":"Le Coz","year":"2013","journal-title":"PLoS ONE"},{"key":"2025090312054826000_10.2.e003991.11","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.58"},{"key":"2025090312054826000_10.2.e003991.12","doi-asserted-by":"crossref","unstructured":"Gensous N , Schmitt N , Richez C , et al . n.d. T follicular helper cells, Interleukin-21 and systemic lupus erythematosus. Rheumatology:kew297. doi:10.1093\/rheumatology\/kew297","DOI":"10.1093\/rheumatology\/kew297"},{"key":"2025090312054826000_10.2.e003991.13","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/art.40180","article-title":"Peripheral Immunophenotyping identifies three subgroups based on T cell heterogeneity in lupus patients","volume":"69","author":"Kubo","year":"2017","journal-title":"Arthrit Rheumatol"},{"key":"2025090312054826000_10.2.e003991.14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/1744666X.2021.1976146","article-title":"Clinical relevance of T follicular helper cells in systemic lupus erythematosus","volume":"17","author":"Nakayamada","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"2025090312054826000_10.2.e003991.15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/art.41457","article-title":"Conversion of T follicular helper cells to T follicular regulatory cells by Interleukin\u20102 through transcriptional regulation in systemic lupus erythematosus","volume":"73","author":"Hao","year":"2021","journal-title":"Arthritis & Rheumatology"},{"key":"2025090312054826000_10.2.e003991.16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/0961203319828530","article-title":"Regulatory T-cell levels in systemic lupus erythematosus patients: a meta-analysis","volume":"28","author":"Zhu","year":"2019","journal-title":"Lupus"},{"key":"2025090312054826000_10.2.e003991.17","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.60"},{"key":"2025090312054826000_10.2.e003991.18","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.33"},{"key":"2025090312054826000_10.2.e003991.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912196"},{"key":"2025090312054826000_10.2.e003991.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00726-8"},{"key":"2025090312054826000_10.2.e003991.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02546-6"},{"key":"2025090312054826000_10.2.e003991.22","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00444"},{"key":"2025090312054826000_10.2.e003991.23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01510"},{"key":"2025090312054826000_10.2.e003991.24","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2025090312054826000_10.2.e003991.25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215089"},{"key":"2025090312054826000_10.2.e003991.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606"},{"key":"2025090312054826000_10.2.e003991.27","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh624"},{"key":"2025090312054826000_10.2.e003991.28","doi-asserted-by":"publisher","DOI":"10.1038\/nri3158"},{"key":"2025090312054826000_10.2.e003991.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.023"},{"key":"2025090312054826000_10.2.e003991.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03750-7"},{"key":"2025090312054826000_10.2.e003991.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0398-x"},{"key":"2025090312054826000_10.2.e003991.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.08.015"},{"key":"2025090312054826000_10.2.e003991.33","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1093\/rheumatology\/keaa176","article-title":"Interleukin-23 drives expansion of Thelper 17 cells through epigenetic regulation by signal transducer and Activators of transcription 3 in lupus patients","volume":"59","author":"Lee","year":"2020","journal-title":"Rheumatology"},{"key":"2025090312054826000_10.2.e003991.34","doi-asserted-by":"crossref","first-page":"27231124","DOI":"10.1038\/srep26494","article-title":"ICOS+PD-1+Cxcr3+ T foLLicular HELper CElls contribute to the generation of high-avidity antibodies following influenza vaccination","volume":"6","author":"Bentebibel","year":"2016","journal-title":"Sci Rep"},{"key":"2025090312054826000_10.2.e003991.35","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.722"},{"key":"2025090312054826000_10.2.e003991.36","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-eular.4518"},{"key":"2025090312054826000_10.2.e003991.37","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-222335"},{"key":"2025090312054826000_10.2.e003991.38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.42391","article-title":"Deucravacitinib, a tyrosine kinase 2 inhibitor, in systemic lupus erythematosus: A phase II, randomized, double-blind, placebo-controlled trial","volume":"75","author":"Morand","year":"2023","journal-title":"Arthritis Rheumatol"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003991","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:05:56Z","timestamp":1756926356000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6,13]]},"published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1136\/rmdopen-2023-003991"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003991","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}